A detailed history of Rothschild Investment LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 30 shares of SAGE stock, worth $145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 270 88.89%
Holding current value
$145
Previous $2.93 Million 92.6%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$7.02 - $13.08 $1,684 - $3,139
-240 Reduced 88.89%
30 $217,000
Q2 2024

Jul 30, 2024

BUY
$10.58 - $17.9 $2,856 - $4,833
270 New
270 $2.93 Million
Q1 2024

Jul 31, 2024

BUY
$18.62 - $26.95 $93 - $134
5 Added 2.0%
255 $4.78 Million
Q4 2023

Jul 31, 2024

SELL
$17.1 - $22.26 $342 - $445
-20 Reduced 7.41%
250 $5.42 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $288M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.